TSANZ SIG Orals: Cystic Fibrosis
Tracks
Track 4
Tuesday, March 26, 2024 |
10:30 AM - 12:00 PM |
Theatrette 1 |
Speaker
Dr Christine Duplancic
Research Officer
University of Queensland
Nontuberculous mycobacteria (NTM) in Australians with cystic fibrosis (CF): A national study
10:30 AM - 10:45 AMBiography
Dr Christine Duplancic has been working as the study coordinator for the National NTM in CF study since 2016. She has a background in bacterial pathogenesis research, obtaining her PhD in molecular microbiology from the University of Wollongong in 2008.
Dr Elena Schneider-Futschik
Senior Research Fellow
University of Melbourne
Fetal drug exposure after maternally administered CFTR modulators Elexacaftor/Tezacaftor/Ivacaftor in a rat model
10:45 AM - 11:00 AMBiography
Dr Elena Schneider-Futschik is a senior research fellow at the University of Melbourne aiming to optimise drug treatments for respiratory diseases. She has received funding from the NHMRC, US CF Foundation and the Australian CF Trust.
Dr Elena Schneider-Futschik
Senior Research Fellow
University of Melbourne
Late pregnancy Elexacaftor/Tezacaftor/Ivacaftor exposure may harm developing thymus and cortex
11:00 AM - 11:15 AMBiography
Dr Elena Schneider-Futschik is a senior research fellow at the University of Melbourne aiming to optimise drug treatments for respiratory diseases. She has received funding from the NHMRC, US CF Foundation and the Australian CF Trust.
Assoc Prof Kathryn Ramsey
Co-head, Children's Lung Health
Telethon Kids Institute
Lung clearance index predicts disease progression in children with cystic fibrosis
11:15 AM - 11:30 AMBiography
A/Prof Kathryn Ramsey is a NHMRC Investigator Fellow and Co-Head of Children’s Lung Health at the Telethon Kids Institute. She leads a translational research program to understand mechanisms and improve outcomes in children with muco-obstructive lung diseases, including cystic fibrosis, bronchiectasis, and primary ciliary dyskinesia.
Dr Lisa Jurak
Research officer
The Prince Charles Hospital
The effects of CFTR modulators on sputum pH
11:30 AM - 11:45 AMBiography
Lisa completed her PhD in 2023 at the University of Queesland in the field of clinical proteomics and severe asthma. She has a special interest in the field of multi-omics, data science and the opportunities it offers when understanding respiratory diseases.
Dr Hannah Corbett
Paediatric Respiratory Fellow
Royal London Hospital
Modulators and Cystic Fibrosis-Related Diabetes – What’s the Difference?
11:45 AM - 12:00 PMBiography
Dr Hannah Corbett is an RACP Advanced Trainee in Paediatric Respiratory Medicine. She has trained at Sydney Children's Hospital, Randwick and in 2023 she undertook a clinical fellowship in Cystic Fibrosis at the Royal London Hospital in the UK. She has an interest in CF-Related Diabetes.
Dr Bernadette Prentice
Respiratory Staff Specialist
Sydney Children's Hospital
Chairperson
10:30 AM - 12:00 PMBiography
Dr Simone Visser
Respiratory Staff Specialist
Royal Prince Alfred Hospital
Chairperson
10:30 AM - 12:00 PMBiography
Simone is a Respiratory Staff Specialist at The Royal Prince Alfred Hospital where she is part of the adult cystic fibrosis service and director of the multidisciplinary bronchiectasis clinic. She is a Senior Lecturer with The University of Sydney and co-convenor of the TSANZ CF-SIG.